Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...
HAMBURG, GERMANY / ACCESSWIRE / November 6, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT) (MDAX/TecDAX, ISIN: DE0005664809) (NASDAQ:EVO) today announced its financial results and corporate updates ...
HAMBURG, GERMANY / ACCESSWIRE / November 6, 2024 / Evotec SE (Frankfurt Stock ... of biosimilars Extension of collaboration with Bristol Myers Squibb ("BMS") based on targeted protein degradation ...
"Developer confidence in the market has diminished significantly, resulting in the sale of underperforming new developments," ...
Bristol Myers Squibb (NYSE: BMY ... taking place October 29 – November 2 in Boston, Massachusetts. “Building on momentum from the recent U.S. Food and Drug Administration’s approval of ...
Knowsley-based housing association, Livv Housing Group, is on track to achieving its current three-year corporate plan target ...
LifeSci Capital is acting as the lead manager for the proposed offering ... with the VC funds of Roche, Pfizer, and Bristol-Myers Squibb joining Angelini Ventures and the JDRF T1D Fund in a ...
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis
Once all papers were selected, they were divided into MS diagnosis and differential diagnosis (N=6), prediction of disease evolution ... She has also received honoraria from Roche, Sanofi, ...
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback